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Influence of Macromolecule Baseline on 1H MR
Spectroscopic Imaging Reproducibility
Rebecca Birch,1,2 Andrew C. Peet,3,4 Hamid Dehghani,5 and Martin Wilson2*
Purpose: Poorly characterized macromolecular (MM) and base-
line artefacts are known to reduce metabolite quantitation accu-
racy in 1H MR spectroscopic imaging (MRSI). Increasing echo
time (TE) and improvements in MM analysis schemes have both
been proposed as strategies to improve metabolite measure-
ment reliability. In this study, the influence of TE and two MM
analysis schemes on MRSI reproducibility are investigated.
Methods: An experimentally acquired baseline was collected
using an inversion recovery sequence (TI¼750ms) and incorpo-
rated into the analysis method. Intrasubject reproducibility of
MRSI scans, acquired at 3 Tesla, was assessed using metabolite
coefficients of variance (COVs) for both experimentally acquired
and simulated MM analysis schemes. In addition, the reproduci-
bility of TE¼35ms, 80ms, and 144ms was evaluated.
Results: TE¼80ms was the most reproducible for singlet
metabolites with COVs<6% for total N-acetyl-aspartate, total
creatine, and total choline; however, moderate multiplet
dephasing was observed. Analysis incorporating the experi-
mental baseline achieved higher Glu and Glx reproducibility at
TE¼35ms, and showed improvements over the simulated
baseline, with higher efficacy for poorer data.
Conclusion: Overall, TE¼80ms yielded the most reproducible
singlet metabolite estimates. However, combined use of a short
TE sequence and the experimental baseline may be preferred as
a compromise between accuracy, multiplet dephasing, and T2
bias on metabolite estimates. Magn Reson Med 000:000–000,
2016. VC 2016 The Authors Magnetic Resonance in Medicine
published by Wiley Periodicals, Inc. on behalf of Interna-
tional Society for Magnetic Resonance in Medicine.
Key words: macromolecule; MRSI; reproducibility; TE;
baseline
INTRODUCTION
1H MR spectroscopic imaging (MRSI) has proven useful
in the mapping of metabolite information across a volume
of interest (VOI) (1–3). The identification of metabolite
biomarkers has been shown to aid the diagnosis and prog-
nosis of numerous diseases, such as brain tumors (4–6),
neurodegenerative diseases (7), and neuro-metabolic dis-
orders (8,9). Various factors can affect the accuracy to
which MRSI data can be quantified, including hardware
performance, data acquisition methods, and subsequent
postprocessing techniques. Short-echo MRSI metabolite
quantitation accuracy can be reduced if macromolecular
(MM) signals, originating from the resonances of cytosolic
proteins and lipids (10,11), are poorly characterized.
These MM signals and any poorly defined baseline arte-
facts contribute to the background signal observed within
MRSI spectra. These background signals can strongly
overlap with metabolites of interest; therefore, any inac-
curacies in MM estimations will decrease the accuracy of
metabolite quantitation during the fitting process; this has
been shown in several studies (12–14).
Several methods have been proposed to decrease the
MM contribution or to characterize it for inclusion in the
fitting process. One method that significantly reduces
these background signals is to increase the echo time
(TE) of the MRS acquisition, taking advantage of the
shorter T2 relaxation times found for MM signals com-
pared with metabolites (15) due to their smaller molecu-
lar weight (10,16). However, at longer TEs, an inherent
reduction in metabolite signal-to-noise ratio (SNR) due
to T2 relaxation, and complex dephasing of multiplets
can reduce quantitation accuracy. Therefore, short-TE
acquisitions may be better suited to measurement of mul-
tiplets and lower SNR metabolites.
The use of MM analysis schemes can help to charac-
terize the MM contribution and account for it in the fit-
ting process (16), improving the reliability of metabolite
estimates. One widely used approach used is to include
individual simulated macromolecule and lipid compo-
nents within the analysis basis set (17). These features
are typically derived from the parameterization of metab-
olite nulled spectra. Seeger et al parameterized the mac-
romolecules by fitting an average MM spectrum to four
broad lines, which included the main MM resonances 1–
7; thus allowing prior knowledge to be introduced into
the spectral fitting (17). MM baseline signals may also be
experimentally acquired using an inversion recovery (IR)
sequence (10) because metabolite signals can be nulled
at inversion time (TI) due to shorter MM T1 relaxation.
Small residual metabolite peaks are generally observed,
but may be removed in post processing. A recent study
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by Snoussi et al (11) determined no significant differen-
ces between MM signals in white and gray matter, sug-
gesting the use of a single MM baseline spectra could be
sufficient to include in a basis set for the fitting of spec-
tra from multiple brain regions.
MRS reproducibility studies are needed to assess reli-
ability for the optimization of imaging protocols. Several
of these have been reported previously; covering a large
range of TEs, field strengths, and techniques (18–24). A
recent study by Deelchand et al combined an experimen-
tal baseline with single voxel 1H MRS (SVS) for two sites
within the brain and found highly reproducible neuro-
chemical profiles could be achieved between scanners
and regions providing optimized protocols were kept con-
sistent (23). Previously comparisons have been made
between the use of simulated baselines and experimental
baselines in the fitting of spectra (12,13,25); however,
their effect on the reproducibility of 2D 1H MRSI data has
not previously been evaluated. In this study we investi-
gate the effect of TE and two MM analysis schemes on the
short-term reproducibility of 1H MRSI data at 3 Tesla (T)
to aid protocol design for clinical studies.
METHODS
All MR scanning was performed on a 3T Philips Achieva
TX MR system with a 32-channel head coil at Birming-
ham Children’s Hospital, UK.
Human Subjects
All volunteers who participated in the study gave
informed consent under full ethical approval.
MRSI Data Collection
All 2D MRSI data were collected from eight healthy vol-
unteers (aged 23–30 years). An initial 3D T1 weighted
anatomical MRI reference scan was obtained for MRSI
grid positioning. All MRSI grids were manually placed
for two regions: (A) above the corpus callosum (three
volunteers), see Figures 1A and 1B; and (B) level with
the basal ganglia (five volunteers), see Figures 1C and
1D, with the following acquisition parameters: field of
view (FOV) matrix size 15 13 voxels; voxel size
13mm 13mm13mm; TR¼ 2 s. Pencil beam shim-
ming was applied. Data were collected at three different
TEs on separate volunteers: TE¼ 35ms (region: A¼ 1
and B¼ 2 volunteers), TE¼ 80ms (region: A¼ 1 and
B¼ 1 volunteer), and TE¼ 144ms (region: A¼1 and
B¼ 2 volunteers). PRESS localization was used to excite
a 66 voxel VOI (78mm 78mm13mm) fixed cen-
trally to the FOV; corresponding to a fully excited 5 5
voxel region with a 1=2 voxel margin around the PRESS
excitation region, edge voxels were discarded in post
processing and the VOI extracted by means of a water
signal threshold. To assess short-term reproducibility, all
scans were acquired in triplicate without grid reposition-
ing; reshimming and water suppression frequency
FIG. 1. Example healthy volun-
teer MRSI grid placement for:
above the corpus callosum sag-
ittal (A) and axial (B) views and
the basal ganglia sagittal (C) and
axial (D) views. Water line width
map is included for corpus cal-
losum (B) and basal ganglia (D)
for the PRESS excitation region.
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optimization in between scans was performed if deemed
necessary. Due to lengthy scanning times, different vol-
unteers were scanned for each TE and region. Absolute
concentrations were obtained by collecting water unsup-
pressed data during the first scan for each volunteer
using the same scanning parameters as the suppressed
(metabolite) data collection.
Spectral Fitting
All spectral analysis was performed using the TARQUIN
software package (26). The TARQUIN algorithm performs a
fully automated fit to the data using a predefined basis set
containing metabolite, lipid and macromolecule signals.
Fitting is performed in the time-domain and constraints,
such as nonnegative metabolite quantities, are enforced to
improve reliability. The simulated MM analysis scheme
(Si.BL) used the following basis set to fit the MRSI
data comprised of 16 individually simulated components:
alanine (Ala); aspartate (Asp); creatine (Cr) -CrCH2; gamma-
aminobutyric acid (GABA); glucose (Glc); glutamine (Gln);
glutathione (Glth); glycerophosphorylcholine (GPC); myo-
inositol (Ins); lactate (Lac); lipid peaks at 0.9, 1.3a, 1.3b, and
2.0ppm; macromolecules at 0.9, 1.2, 1.4, and 2.0ppm;
N-acetyl-aspartate (NAA); N-acetyl-aspartateglutamate
(NAAG); phosphorylcholine (PCho); Phosphocreatine
(PCr); scyllo-inositol (s-Ins); and taurine (Tau). All metabo-
lite components were simulated in TARQUIN using chemi-
cal shift and J coupling values from Govindaraju et al (27).
The simulated MM signal is taken to be the combination of
the individual MM and lipid components listed in the
paper describing the TARQUIN algorithm (26) (Table 1).
Experimental Baseline Model Derivation (Ex.BL)
A single voxel spectroscopy (SVS) inversion recovery
sequence was used to acquire metabolite nulled data
for improved MM determination (TE/TR¼ 35/2500ms
PRESS excitation). An initial experiment was performed
to establish the optimal inversion time for metabolite sig-
nal nulling. Spectra were acquired for TI¼ 500,650 to
850ms in 50ms steps and an optimal TI¼ 750ms was
determined. SVS inversion recovery data was collected
from seven healthy volunteers (aged 23–30 years) from
left and right parietal white matter regions. Ten voxels
were chosen across the seven volunteers due to their
high spectral quality, i.e., free from artefacts caused by
spurious echoes and inefficient water suppression. These
data were then compiled to create an average MM spec-
trum. The average spectrum was subsequently fitted
using TARQUIN to obtain a noise free model of the MM
baseline. A macromolecule basis set composed of Gaus-
sian peaks was initially constructed based on known
peak positions and visual inspection. This basis set was
fit to the average spectrum allowing peak amplitudes,
widths and frequencies to be optimized. The basis set
was then updated with the newly determined frequen-
cies and peak widths and this process of basis set refine-
ment was repeated until fitting resulted in negligible
adjustment to the basis set (Table 1). In addition to MM
signals, narrow metabolite signals for NAA, NAAG, total
choline (tCho), tCr, and tCrCH2 were also included in
the basis set to account for metabolite signals that were
partially nulled (Fig. 2). Finally, the optimized macro-
molecule peaks (excluding residual metabolite signals)
were summed and added to a basis set of metabolite sig-
nals (described above), replacing the individual MM and
lipid components. Analysis using this experimentally
derived baseline model will be referred to as Ex.BL.
Data Analysis
MRSI spectra exported from the scanner workstation in
DICOM format were imported into TARQUIN. Spectra
Table 1
Ex.BL and Its 13mm Components Detailed According to Ampli-
tude, Frequency, and FWHM
Name Amplitude (AU) Freq (PPM) FWHM (Hz)
MM09 0.72 0.90 21.20
MM12 0.28 1.21 19.16
MM14 0.38 1.38 15.90
MM16 0.05 1.63 7.50
MM20 0.45 2.01 29.03
MM21 0.36 2.09 20.53
MM23 0.36 2.25 17.89
MM26 0.04 2.61 5.30
MM30 0.20 2.96 14.02
MM31 0.11 3.11 17.89
MM37 0.64 3.67 33.52
MM38 0.07 3.80 11.85
MM40 1.00 3.96 37.48
FIG. 2. Average Ex.BL MM Spectra spectrum taken from seven
healthy volunteers split into MM and residual metabolite
components.
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were fitted with two different basis sets: one including
the Ex.BL and another that models the MM baseline
using a set of individually simulated MM resonances
(Si.BL). Subsequent data analysis was performed using
Python programming language. Metabolite coefficients of
variance (COVs) were calculated as the voxel wise ratio
of the standard deviation and mean for each volunteer
and TE over the three MRSI acquisitions. COVs were
then grouped according to TE, irrespective of region, and
a mean COV for each metabolite calculated. This was
performed to avoid regional bias with respect to data
quality. The VOI was extracted by means of a water
amplitude threshold and only voxels with a water line
width <0.1 ppm (12.8Hz) were analyzed. Water line
width was defined as the full width half maximum
(FWHM) of the unsuppressed water peak in frequency
domain. The unsuppressed water peak was taken to be
out measure of data quality due to its robustness in com-
parison with metabolite line width, which can become
unstable with noise and artifacts. We also assume that
the water line width is directly correlated with metabo-
lite FWHM and, therefore, can be used as a proxy for
data quality. Metabolite COVs were calculated to assess
technical reproducibility for TE¼ 35, 80, and 144ms
comparing the two MM analysis schemes: (1) Ex.BL and
(2) Si.BL. COVs for the following metabolites were eval-
uated: total NAA (tNAA), total Cr (tCr), tCho, glutamate
(Glu), glutamine (Gln), GluþGln (Glx), Tau, Glth, and
Ins. An analysis of variance (ANOVA) test was per-
formed for the metabolite COVs to test if a difference
between the data sets from TE¼35, 80, and 144ms were
significant. Subsequent unpaired t-tests were carried out
to assess the statistical significance of any differences in
reproducibility in comparison with TE¼ 80ms, those
with P< 0.05 were deemed significant.
Average white matter metabolite concentrations were
also calculated to validate quantitation methodology.
Metabolite concentrations were measured from white
matter voxels selected using the axial T1 anatomical
image registered to the MRSI grid. Average metabolite
concentrations for 36 white matter voxels were taken
from the slice going through the corpus callosum (12
from each scan) for TE¼35, 80, and 144ms (3 volunteers
total). This was done for both Si.Bl and Ex.Bl MM analy-
sis schemes and a percentage difference in concentration
was calculated between these two fitting methods. T2
relaxation correction was applied assuming a T2 of water
of 60ms and metabolite T2 of 200ms.
RESULTS
Impact of TE and Ex.BL on Spectral Fitting
The average MM spectrum across seven volunteers is
shown in Figure 2 and the properties of the MM spectra
decomposed into its 13 components are listed in Table
1. An example of the effect of the Ex.BL on the fitting of
short TE spectra can be observed in Figures 3A and 3B.
Broad background signals (obtained from a 50 data point
moving average filter of the fit residual) are reduced
with the inclusion of a better defined MM spectral con-
tent in comparison with a Si.BL. An increase in TE to 80
and 144ms also reduced the level MM content relative
to metabolites due to shorter T2 relaxation times (Figs.
3C, 3D). A reduction in SNR is also observed with
increasing TE due to T2 relaxation and dephasing of
metabolite multiplets.
Effect of TE and MM Analysis Schemes on
Reproducibility
Table 2 shows metabolite COV for voxels containing
spectra that meet the water line width value criteria
<0.1 ppm. Overall, COVs across the three TEs (35, 80,
and 144ms) were found to be statistically different by
means of an ANOVA test for the following metabolites:
tNAA, tCr, Glu, Gln, Ins, Glth, and Tau (P<0.00001) for
both the Si.BL and Ex.BL MM analysis scheme. Ex.BL
Glx COV was also found to be statistically different
(P¼ 0.0001). A TE¼ 80ms was found to be the most
reproducible with CoVs<9% for tNAA, tCho, and tCr.
Additionally, TE¼ 80ms showed improved reproducibil-
ity over TE¼ 35ms (P< 0.01) for five of the metabolites
analyzed: tNAA, tCr, Gln, Glth, and Tau for both MM
analysis schemes (Table 2).
Across all TEs the most reproducible metabolites were
found to be tNAA, tCr, and tCho with COVs< 13%.
Higher variation at TE¼ 80ms compared with TE¼35ms
was observed for Ex.BL Glu (P< 0.01) and Ex.BL Glx
(P< 0.05) likely due to signal dephasing, therefore, a
short echo acquisition maybe preferred depending on
metabolite of interest. Long TE¼ 144ms was found to
have the highest variation between scans with Ex.BL
COVs tNAA¼ 7.81%, tCr¼ 10.91%, and tCho¼ 9.61%;
compared with 7.56%, 9.25%, and 9.4% for TE¼35ms
and 5.35%, 7.22%, and 8.1% for TE¼ 80ms, respectively
(Table 2). The use of an Ex.BL significantly reduces vari-
ation for TE¼35ms compared with a Si.BL for tNAA,
Glu, Glx, and Tau (P< 0.01). However, a Si.BL provided
significantly better reproducibility for the measurement
of Glth (P< 0.05).
Effect of Line width and MM Analysis Schemes on
Reproducibility
In addition to TE and analysis methodology, data quality
is known to have a significant impact on the reproduci-
bility of MRS data. Therefore, voxels were stratified into
three line width groups: “good” 0–0.06ppm (Table 3),
“acceptable” 0.06–0.1ppm (Table 4), and “poor” 0.1–
0.15ppm (Table 5) to investigate impact of line width on
reproducibility. For tNAA, a 35% improvement in COV
was observed between “good” (Table 3) and “acceptable”
(Table 4) data using a Si.BL analysis, whereas a smaller
improvement of 22% was found for the Ex.BL analysis.
Improved reproducibility for the Ex.BL analysis was
found for poorer water line widths when compared with
Si.BL analysis. The Ex.BL analysis resulted in a large
reduction of 38% in the COV of tNAA for line widths
between 0.1 and 0.15 ppm (Table 5). Smaller reductions
of 30% and 15% were found for line widths bet-
ween 0.06–0.1ppm and 0.0–0.06ppm, respectively.
Improved agreement in reproducibility between the two
analysis methods was found with increasing TE for
tNAA, tCr, tCho, Glx, and Tau (Tables [3 and 4]), likely
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due to the reduction in interference from MM signals at
longer TEs.
The effect of imaging region on water line width can be
observed in Figures 1B and 1D; with a line width approxi-
mately three times higher for the basal ganglia imaging
slice compared with a higher slice above the corpus cal-
losum. Across both regions, a mean water line width of
0.07, 0.07, and 0.06ppm were observed for TE¼35, 80,
and 144ms, respectively for voxels analyzed with the
water line width criteria of <0.1 ppm. Poor line widths
FIG. 3. Example healthy volunteer spectra split into four components: data, fit, MM analysis scheme (Si.BL or Ex.BL) and residual back-
ground signal for three TEs: TE¼35ms (Si.BL) (A); TE¼35ms (Ex.BL) (B); TE¼80ms (Si.BL) (C); and TE¼144ms (Si.BL) (D).
Table 2
Metabolite COVs for Voxels Containing Spectra That Meet Overall Water Line Width Criteriaa
0-0.1 ppm
TE¼35ms TE¼80ms TE¼144ms Echo time comparison
Line width
COV % COV % COV % ANOVA
Metabolite Si.BL Ex.BL Si.BL Ex.BL Si.BL Ex.BL Si.BL Ex.BL
tNAAyy¥¥ 9.99 7.56 6.03 5.35 12.31 7.81 <0.00001 <0.00001
tCr 10.13 9.25 7.18 7.22 11.56 10.91 <0.00001 <0.00001
tCho 9.00 9.40 8.16 8.10 9.78 9.61 0.1209 0.1027
Gluyy 20.35 16.33 22.36 22.82 45.96 47.57 <0.00001 <0.00001
Gln¥ 83.80 88.85 56.22 60.19 47.37 53.22 <0.00001 <0.00001
Glxyy¥ 24.85 19.95 22.81 23.25 22.49 25.39 0.1525 0.0001
Ins 15.36 15.36 16.97 17.87 34.46 33.84 <0.00001 <0.00001
Glthy 48.43 68.14 28.33 27.67 69.06 68.39 <0.00001 <0.00001
Tauyy 127.97 89.93 70.56 70.56 70.71 66.25 <0.00001 <0.00001
aMetabolite COVs for TE¼35, 80, and 144ms for voxels containing spectra that meet the overall water line width criteria of between 0
and 0.1 ppm showing significant (P<0.05) differences from an unpaired t-test between Si.BL and Ex.BL for TE¼35ms (y), TE¼80ms
(z), and TE¼144ms (¥). Significances of P<0.01 are denoted as: TE¼35ms (yy), TE¼80ms (zz), and TE¼144ms (¥¥).
Influence of MM Baseline on MRSI Reproducibility 5
were particularly observed in the frontal region of the basal
ganglia slice through the brain. Magnetic field inhomoge-
neity is commonly observed in MRSI data when there is a
close proximity to air-tissue interfaces (28) such as the
sinuses, resulting in spectral line broadening. Poor line
width increased fitting error resulting in a reduction in
overall reproducibility. For a TE of 35ms, 38% of the total
voxels across all scans and volunteers were discarded due
to poor line width (>0.1ppm); compared with 14% and
3% for TE¼ 80ms and 144ms, respectively. Analysis
showed that the location of these voxels for the short echo
data were predominantly in the basal ganglia region.
Effect of TE and MM Analysis Schemes on Metabolite
Quantitation
Average white matter metabolite concentrations were
also calculated to validate quantitation methodology.
Table 6 shows the absolute concentrations for the metab-
olites taken from white matter for each TE and a compar-
ison between Si.BL and Ex.BL analysis schemes. For
TEs¼ 35 and 80ms, absolute concentrations were found
to be consistent with those found in literature for healthy
parietal white matter (19,29). However, a slight underes-
timation was observed for TE¼ 144ms suggesting accu-
racy may be reduced at long TEs due to increased T2
relaxation. It is also worth noting that differences in
metabolite concentrations across TE could be attributed
to natural variability across volunteers. The percentage
difference in concentration between Si.BL and Ex.BL
MM analysis schemes was found to be below 23% across
all TEs for tNAA, tCr, and tCho. Larger differences were
observed for poorly determined metabolites such as Gln,
Glth, and Tau, particularly at TE¼ 35ms.
DISCUSSION
The effect of TE and MM analysis schemes on the repro-
ducibility of 1H MRSI has been evaluated for three differ-
ent TEs (35, 80, and 144ms) and a comparison made
between two different MM analysis schemes Si.BL and
Ex.BL. Overall, a TE¼ 80ms was found to be signifi-
cantly more reproducible for five metabolites: tNAA, tCr,
Gln, Glth, and Tau. For the determination of Glu and
Table 3
Metabolite COVs for Voxels Containing Spectra That Meet “Good” Water Line Width Criteriaa
0-0.06ppm
TE¼35ms TE¼80ms TE¼144ms Echo time comparison
Line width
COV % COV % COV % ANOVA
Metabolite Si.BL Ex.BL Si.BL Ex.BL Si.BL Ex.BL Si.BL Ex.BL
tNAA¥¥ 7.79 6.59 4.07 3.81 10.96 7.55 <0.00001 <0.00001
tCry 10.52 8.69 4.70 4.25 10.19 9.90 <0.00001 <0.00001
tCho 8.16 8.19 5.91 5.75 9.16 8.81 <0.05 <0.05
Gluyy 17.30 13.73 16.80 17.87 37.08 41.52 <0.00001 <0.00001
Gln 83.98 93.24 41.61 46.79 46.91 52.31 <0.00001 <0.00001
Glxyy 19.54 15.39 18.55 19.80 22.01 24.50 <0.05 <0.00001
Ins 15.94 15.69 10.24 10.94 27.00 27.22 <0.00001 <0.00001
Glth 33.08 38.41 27.34 25.37 62.60 61.22 <0.00001 <0.00001
Tauyy 127.87 89.93 62.30 60.61 60.63 56.44 <0.00001 <0.00001
aMetabolite COVs for TE¼35, 80, and 144ms for voxels containing spectra that meet the “good” water line width criteria of between 0
and 0.06ppm showing significant (P<0.05) differences from an unpaired t-test between Si.BL and Ex.BL for TE¼35ms (y), TE¼80ms
(z), and TE¼144ms (¥). Significances of P<0.01 are denoted as: TE¼35ms (yy), TE¼80ms (zz), and TE¼144ms (¥¥).
Table 4
Metabolite COVs for Voxels Containing Spectra That Meet “Acceptable” Water Line Width Criteria
0.06-0.1ppm
TE¼35ms TE¼80ms TE¼144ms Echo time comparison
Line width
COV % COV % COV % ANOVA
Metabolite Si.BL Ex.BL Si.BL Ex.BL Si.BL Ex.BL Si.BL Ex.BL
tNAAyy¥¥ 11.94 8.41 6.77 5.92 14.73 8.27 <0.00001 <0.0001
tCr 9.78 9.74 8.12 8.33 14.02 12.73 <0.00001 <0.001
tCho 9.75 10.47 9.00 8.98 10.89 11.03 0.2815 0.1056
Gluy 23.06 18.63 24.45 24.68 62.45 59.21 <0.00001 <0.00001
Gln 83.65 85.64 61.78 65.36 48.18 54.81 <0.00001 <0.00001
Glxy 29.56 23.99 24.41 24.54 23.34 26.99 0.01 0.3328
Ins 14.85 15.06 19.49 20.47 47.85 45.72 <0.00001 <0.00001
Glthy 63.00 102.50 28.71 28.53 92.26 88.03 <0.00001 <0.00001
Tauyy 128.16 96.08 73.74 74.43 91.93 86.37 <0.00001 <0.01
aMetabolite COVs for TE¼35, 80, and 144ms for voxels containing spectra that meet the “acceptable” water line width criteria of
between 0.06 and 0.1ppm showing significant (P<0.05) differences from an unpaired t-test between Si.BL and Ex.BL for TE¼35ms (y),
TE¼80ms (z), and TE¼144ms (¥). Significances of P<0.01 are denoted as: TE¼35ms (yy), TE¼80ms (zz), and TE¼144ms (¥¥).
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Glx, however, a TE¼ 35ms in conjunction with Ex.BL
performed significantly better.
As expected, the most reproducible metabolites were
found to be tNAA, tCr, and tCho due to their higher SNR
resulting in an increase in their fitting precision. The
improved reproducibility with the use of an Ex.BL com-
pared with a Si.BL in the fitting of short echo spectra
was found to be significant for four metabolites: tNAA,
Glu, Glx, and Tau. In addition, increased improvements
were observed for spectra with poorer line widths, sug-
gesting the Ex.BL method could be used to improve the
reliability of poor quality data.
A recent study by Veenith et al (30) found within ses-
sion reproducibility COVs of 9.9% for tNAA, 10.6% tCr,
and 14.3% for tCho at TE¼ 70ms compared with our
values of 6.03%, 7.18%, and 8.16% for tNAA, tCr, and
tCho, respectively, using a simulated MM baseline at
TE¼ 80ms. A slight improvement was observed for
TE¼ 80ms with the use of an Ex.BL for these metabolites
with COVs of 5.35% and 8.1% for tNAA and tCho,
respectively, within our study. Improved reproducibility
found within our study at intermediate TE could be
attributed to several differences in methodology, some of
which include: SPIN-ECHO versus PRESS acquisition,
the use different analysis software and a slightly differ-
ent line width threshold of <12Hz. Our protocol also
had a slightly greater TE, allowing further decay of MM
signals, potentially reducing the influence of these sig-
nals on the overall reproducibility.
Another study by Gasparovic et al (31) at 3T used a
short TE of 40ms and found comparable COVs of 5% for
tNAA, 6% Cr, 7% Cho, 11% Ins, 10% Glu, and 13% for
Glx. Their TE¼ 40ms was chosen for optimized detec-
tion of Glu. Additionally, a study by Jang et al (32) at
1.5T also found an optimal short TE of 40ms using
PRESS for the measurement of Glu with comparable
COVs of 11 and 13.1% for anterior cingulate cortex and
insula, respectively. In our study at TE¼ 35ms, a COV of
16.33% was found for Glu which may be because our
sequence has not been specifically optimized for Glu.
There is growing interest in MRS measures of Glu for
the study of schizophrenia (33); brain tumor metabolism
(34), and cognition (35). In this study, the combination
of Ex.BL and a 35ms TE yielded the most reproducible
measure of Glu (COV¼ 14%). This finding is in agree-
ment with a previous study by Hancu, where simula-
tions and in vivo data were used to demonstrate that
shorter TE acquisitions showed better reproducibility for
Glu measurements (36). Work by Mullins et al also found
a shorter TE to be optimal for Glu with COVs of 2.6% for
TE¼ 40ms and 7.6% for TE¼ 80ms (37). Contrary to
this, a study by Schubert et al (38), assessed the determi-
nation of Glu using SVS at 3T, proposed an intermediate
TE of 80ms to be optimal. However, Schubert et al
focused on TEs between 50ms and 330ms and did not
evaluate short-echo spectra< 50ms.
In addition, MM signals were not included in the anal-
ysis basis set, therefore, analysis of TEs shorter than
50ms would have resulted in greater interference from
Table 5
Metabolite COVs for Voxels Containing Spectra That Meet “Poor”
Water Line Width Criteriaa
0.1-0.15ppm
TE¼35ms TE¼80ms
Line width
COV % COV %
Metabolite Si.BL Ex.BL Si.BL Ex.BL
tNAAyyzz 23.09 14.39 12.96 6.53
tCr 15.53 14.92 10.21 10.22
tCho 15.15 14.17 18.44 17.44
Glu 30.62 27.46 44.72 40.21
Gln 56.13 56.46 92.37 101.36
Glx 23.99 23.75 42.56 38.28
Ins 27.85 27.22 34.79 38.10
Glthy 103.15 121.31 44.15 46.19
Tau 141.42 131.06 73.90 77.15
aMetabolite COVs for TE¼35 and 80ms for voxels containing
spectra that meet the “poor” water line width criteria of between
0.1 and 0.15ppm showing significant (P<0.05) differences from
an unpaired t-test between Si.BL and Ex.BL for TE¼35ms (y),
TE¼80ms (z), and TE¼144ms (¥). Significances of P<0.01 are
denoted as: TE¼35ms (yy), TE¼80ms (zz), and TE¼144ms (¥¥).
Table 6
Average Healthy Volunteer Metabolite Concentrations for Left and Right White Mattera
TE¼35ms TE¼80ms TE¼144ms
Metabolite
Mean
concentration
(mmol)
D (%)
Mean
concentration
(mmol)
D (%)
Mean concentration
(mmol)
D (%)Si.BL Ex.BL Si.BL Ex.BL Si.BL Ex.BL
tNAA 7.0 6.5 7.2 7.6 7.8 1.3 5.7 6.6 14.7
tCr 4.9 4.5 9.3 3.6 3.5 1.4 2.3 2.3 0.1
tCho 1.4 1.3 9.1 1.1 1.1 1.6 1.0 1.0 3.6
Glu 5.2 5.3 2.9 4.0 4.0 0.0 1.0 0.9 17.2
Gln 0.8 0.5 45.3 0.5 0.5 10.2 1.2 1.0 17.5
Glx 6.0 5.8 3.9 4.5 4.5 1.2 2.2 1.8 17.4
Ins 2.8 2.9 3.5 3.6 3.5 1.8 1.3 1.3 0.3
Glth 1.0 0.3 66.1 0.7 0.8 1.1 0.2 0.2 34.5
Tau 0.1 0.5 543.6 0.4 0.4 1.8 0.4 0.4 2.9
aAverage healthy volunteer metabolite concentrations for left and right white matter for TE¼35, 80, and 144ms for both Ex.BL and
Si.BL MM analysis schemes. A percentage difference D between Si.BL and Ex.BL is also shown.
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MM signals. At TE¼80ms, a COV of 17% for Glu was
achieved in this study compared with 10% from Schu-
bert et al, this difference may be attributed to the gener-
ally higher data quality available from SVS. Although
this study was focused on MRSI, it is worth noting that
the findings here broadly agree with similar SVS studies
measuring Glu. This indicates our results may also be
applicable to the design of SVS studies. Hancu and Port
et al (39) suggest a TE¼ 80ms is optimal for Gln with in
vivo COVs of 12.7% compared with 122% for a
TE¼ 35ms. Due to dephasing a shorter TE was better for
Glu with simulation COVs of 4.2% for TE¼ 35ms and
5.1% for TE¼ 80ms. This finding is in agreement with
our study. Our study, however, shows increased varia-
tion for Glu as expected in vivo when compared with
simulation. J-modulation effects for Glu at longer TE
could explain why Glu is dephased at longer TE,
whereas Gln can still be reliably measured. It is also
worth noting that as Gln is present in low levels its
reproducibility can be difficult to determine accurately.
Increased MRS measures of Lac are thought to be asso-
ciated with hypoxia or ischemia; therefore, this signal is
widely measured in clinical MRS studied to investigate
pathologies such as brain tumors and mitochondrial dis-
ease (40). A TE of 144ms is often used for the measure-
ment of Lac, due to a characteristic signal inversion at
this TE and improved separation for lipid signals at
1.3 ppm (40,41). Due to the low levels of Lac in normal
brain, this metabolite was not considered in this study;
however, this example highlights that a single TE may
not be optimal for all metabolites. Therefore, protocol
optimization will always benefit from prior knowledge of
the important metabolites for a particular clinical ques-
tion. However, in the absence of a prior hypothesis, a
shorter TE with appropriate MM and lipid analysis will
give good results for most metabolites due to reduced
multiplet dephasing and T2 weighting.
It is worth noting that, in addition to metabolites, MM
spectral information is also of clinical interest, since it
has been shown to provide useful information for several
diseases, such as brain tumors where MM content was
found to be useful in assigning tumor grade (42). A
recent study by Craveiro et al has shown that mouse
models of human glioma have exhibited several altera-
tions in the macromolecule spectrum when compared
with healthy controls corresponding to mobile lipids and
also a broad MM component between 3.6 and 3.7ppm.
This introduced significant errors into the quantification
of Lac and Asp (43). Therefore, any difference in MM
content due to pathology may need to be accounted for
to maintain accurate metabolite quantification. This also
suggests that a MM fitting model based on normal tissue
may not be suitable for the analysis of some pathology.
Elevated levels of MM have also been observed in stud-
ies of multiple sclerosis (44) and stroke (45,46). How-
ever, the acquisition of MM spectra using an inversion
recovery sequence for each patient would prove time
consuming and may preclude its use for routine clinical
use. Therefore, because pathology MM content is likely
to differ from normative profiles in some diseases, the
more flexible Si.BL analysis method should be chosen in
the absence of a patient or disease specific MM profile.
Whereas both TE and MM analysis schemes can influ-
ence the reproducibility of 1H MRSI spectra, data quality
parameters such as water line width and SNR also have
a significant impact. TE is inherently linked with SNR;
therefore, it is an important factor to consider for proto-
col optimization. Loss of signal limits the amount of
metabolite information that can be observed at increased
TEs, as lower level signals get closer to background lev-
els decreasing fitting accuracy. Water line width is
another issue that can influence the reproducibility of
spectra. It can be observed from Table 5 that, if a rejec-
tion criterion is not set, the available reproducibility for
each metabolite can increase drastically. For example, a
twofold change in reproducibility can be observed in the
case of tNAA compared with water line width
<0.01ppm. Water line width is also dependent on imag-
ing location, meaning voxel placement may become an
issue in protocol design. In this study, poorer water line
widths were observed for spectra collected with a slice
going through the basal ganglia, particularly in the fron-
tal region, due a closer proximity to susceptibility induc-
ing air–tissue boundaries, e.g., sinuses. This proved
particularly problematic for short-echo spectra, resulting
in the rejection of over a third of voxels due to water
line width (>0.01ppm). This loss of information would
prove particularly disadvantageous if the voxels dis-
carded are located in an area of pathological interest.
Although an apparent relationship between TE and
water line width was observed in our data, we regard
this as a chance observation arising from random subject
variability, rather than a causal relationship.
This study demonstrates several factors to be consid-
ered in MRSI protocol optimization including: TE, MM
analysis schemes, metabolite of interest, location and
data quality, all which are not necessarily independent
from each other. This study mainly focuses on the intra-
subject reproducibility within the same session rather
than accuracy. Metabolite concentrations were calculated
for each TE and MM analysis scheme and were found to
be consistent with those previously published in litera-
ture for parietal white matter (19,29). A slight underesti-
mation was found for a TE¼ 144ms, suggesting accuracy
is decreased at longer TE, which could be due to T2 bias
on the metabolite estimates. True measures of accuracy
are difficult to establish in volunteers and patients due
to a lack of alternative methods for measuring NMR visi-
ble metabolite concentrations. For this reason, partial
volume corrections for white matter, gray matter, and
cerebrospinal fluid were not required for this study, as
COV measured were only performed between voxels
with identical tissue constituents. Further work is
needed to develop methods for establishing combined
reproducibility and accuracy.
CONCLUSIONS
In this study, TE, MM baseline analysis, and data quality
were all found to impact the reproducibility of 1H MRSI
data. These results highlight the importance of careful
selection of TE and analysis methodology where optimal
reproducibility is sought for a primary metabolite of
interest. Overall, this study found that a TE¼80ms
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produced the most reproducible metabolite values for
tNAA, tCho, tCr, and Glth in healthy volunteers. How-
ever, the combined use of a short TE sequence and the
MM analysis scheme Ex.BL may be preferred as a com-
promise between good accuracy, good SNR and T2 bias
on metabolite estimates.
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